T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$4.95B |
| 2 |
Broadcom
AVGO
|
+$3.48B |
| 3 |
Microsoft
MSFT
|
+$2.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.92B |
| 5 |
GE Aerospace
GE
|
+$1.49B |
Top Sells
| 1 |
Amazon
AMZN
|
+$3.79B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.63B |
| 3 |
Apple
AAPL
|
+$2.46B |
| 4 |
Fiserv
FI
|
+$2.19B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| 1 | Technology | 34.76% |
| 2 | Financials | 12.08% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RZLV
2801
Rezolve AI PLC Ordinary Shares
RZLV
$1.52B
| $140K | ﹤0.01% |
+45,576
| New | +$140K |
|
2802
Arteris
AIP
$369M
| $139K | ﹤0.01% |
14,498
+2,200
| +18% | +$21.1K |
|
2803
Entravision Communication
EVC
$215M
| $139K | ﹤0.01% |
59,813
-515
| -0.9% | -$1.2K |
|
2804
American Well
AMWL
$106M
| $138K | ﹤0.01% |
15,498
-407
| -3% | -$3.62K |
|
2805
Comtech Telecommunications
CMTL
$65.3M
| $138K | ﹤0.01% |
56,107
-836
| -1% | -$2.06K |
|
2806
iRobot
IRBT
$107M
| $138K | ﹤0.01% |
43,940
-13,136
| -23% | -$41.3K |
|
2807
Marine Products Corp
MPX
$317M
| $138K | ﹤0.01% |
16,155
+1,487
| +10% | +$12.7K |
|
2808
Ranpak Holdings
PACK
$407M
| $138K | ﹤0.01% |
38,584
+2,298
| +6% | +$8.22K |
|
2809
Paysign
PAYS
$281M
| $137K | ﹤0.01% |
18,928
+4,328
| +30% | +$31.3K |
|
2810
Mama's Creations
MAMA
$363M
| $135K | ﹤0.01% |
16,245
+1,940
| +14% | +$16.1K |
|
2811
Neuropace
NPCE
$320M
| $135K | ﹤0.01% |
+12,058
| New | +$135K |
|
2812
Altimmune
ALT
$324M
| $133K | ﹤0.01% |
34,231
+2,753
| +9% | +$10.7K |
|
2813
Senseonics Holdings
SENS
$357M
| $133K | ﹤0.01% |
281,518
-7,382
| -3% | -$3.49K |
|
|
PHLT
2814
Performant Healthcare, Inc. Common Stock
PHLT
$604M
| $133K | ﹤0.01% |
33,248
+3,513
| +12% | +$14.1K |
|
2815
Esperion Therapeutics
ESPR
$524M
| $132K | ﹤0.01% |
134,514
+8,961
| +7% | +$8.79K |
|
2816
4D Molecular Therapeutics
FDMT
$324M
| $132K | ﹤0.01% |
35,328
+8,800
| +33% | +$32.9K |
|
2817
Humacyte
HUMA
$234M
| $132K | ﹤0.01% |
62,842
+25,252
| +67% | +$53K |
|
2818
Treace Medical Concepts
TMCI
$442M
| $131K | ﹤0.01% |
22,117
+1,118
| +5% | +$6.62K |
|
2819
Alto Neuroscience
ANRO
$96.4M
| $131K | ﹤0.01% |
59,428
+5,499
| +10% | +$12.1K |
|
2820
Fossil Group
FOSL
$159M
| $129K | ﹤0.01% |
86,628
-2,272
| -3% | -$3.38K |
|
2821
Neuronetics
STIM
$228M
| $129K | ﹤0.01% |
36,861
+17,761
| +93% | +$62.2K |
|
2822
DocGo
DCGO
$148M
| $128K | ﹤0.01% |
81,037
+4,420
| +6% | +$6.98K |
|
2823
Olema Pharmaceuticals
OLMA
$536M
| $128K | ﹤0.01% |
29,861
+12,325
| +70% | +$52.8K |
|
2824
Century Casinos
CNTY
$75.1M
| $127K | ﹤0.01% |
59,831
-1,569
| -3% | -$3.33K |
|
2825
Savara
SVRA
$662M
| $127K | ﹤0.01% |
55,667
+3,545
| +7% | +$8.09K |
|